{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:34:47Z","timestamp":1787135687790,"version":"build-2736575974"},"reference-count":43,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2026,5,25]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Pulmonary aspergillosis is a rare, high mortality lung infection caused by the\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      sp. Chronic lung diseases and immunosuppression are known risk factors, but data on the impact of corticosteroids and their route of administration are limited.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To evaluate the association between corticosteroid use and pulmonary aspergillosis, we conducted a retrospective case\u2013control study in all Danish citizens who redeemed at least one prescription for inhaled medicine between 1994 and 2025. We identified 1351 patients with aspergillosis other than allergic bronchopulmonary aspergillosis (ABPA) and matched them to controls (1:5) by age, sex and calendar year using risk set sampling. Conditional logistic regression was used to estimate adjusted incidence rate ratios (aIRRs) for chronic pulmonary aspergillosis (CPA) and invasive pulmonary aspergillosis (IPA) across dose categories and 90-day exposure windows. The use of risk-set sampling allowed for estimating IRRs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Inhaled corticosteroids were associated with non-ABPA aspergillosis in a dose-dependent manner (aIRR 1.7 (95% CI 1.3 to 2.2) for use \u2264640 \u00b5g\/day, aIRR 2.8 (2.2 to 3.6) for use &gt;640 \u00b5g\/day, compared with no use) but only associated with IPA for higher doses. Oral corticosteroids (OCS) were similarly associated with non-ABPA aspergillosis (aIRR 3.0 (95% CI 2.2 to 4.1) for OCS use \u22645.6 mg\/day, aIRR 4.0 (2.9 to 5.4) for OCS use &gt;5.6 mg\/day, both compared with no use), affecting both CPA and IPA. The risk decreased with increasing time since exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results demonstrate a strong and seemingly dose-dependent association between both systemic and inhaled corticosteroid use and aspergillosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thorax-2026-225007","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:20:32Z","timestamp":1785518432000},"page":"thorax-2026-225007","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Inhaled and oral corticosteroid use and the risk of pulmonary aspergillosis: a Danish population-based case\u2013control study"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5684-9375","authenticated-orcid":false,"given":"Alexander","family":"Jordan","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Gentofte University Hospital, Hellerup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise Lindhardt","family":"Toennesen","sequence":"additional","affiliation":[{"name":"Hvidovre Hospital Department of Respiratory Medicine, Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2137-8412","authenticated-orcid":false,"given":"B\u00e5rd-Emil Vang","family":"Gundersen","sequence":"additional","affiliation":[{"name":"Copenhagen respiratory research, Gentofte Hospital, Hellerup, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Ulrik St\u00e6hr","family":"Jensen","sequence":"additional","affiliation":[{"name":"Section of Respiratory Medicine, Department of Medicine, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen Faculty of Health and Medical Sciences, Copenhagen, Denmark"},{"name":"PERSIMUNE&CHIP: Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"2026073110201957000_thorax-2026-225007v1.1","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00001011"},{"key":"2026073110201957000_thorax-2026-225007v1.2","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myy076"},{"key":"2026073110201957000_thorax-2026-225007v1.3","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12141"},{"key":"2026073110201957000_thorax-2026-225007v1.4","first-page":"673","article-title":"Chronic Pulmonary Aspergillosis: A Brief Review","volume":"94","author":"Zarif","year":"2021","journal-title":"Yale J Biol Med"},{"key":"2026073110201957000_thorax-2026-225007v1.5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00583-2015"},{"key":"2026073110201957000_thorax-2026-225007v1.6","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00054810"},{"key":"2026073110201957000_thorax-2026-225007v1.7","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1086\/376526","article-title":"Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review","volume":"37 Suppl 3","author":"Denning","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2026073110201957000_thorax-2026-225007v1.8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.112.2.541"},{"key":"2026073110201957000_thorax-2026-225007v1.9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01062-2016"},{"key":"2026073110201957000_thorax-2026-225007v1.10","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.3109\/13693786.2010.505204","article-title":"Clinical risk factors for invasive aspergillosis","volume":"49 Suppl 1","author":"Baddley","year":"2011","journal-title":"Med Mycol"},{"key":"2026073110201957000_thorax-2026-225007v1.11","doi-asserted-by":"crossref","unstructured":"Jenks JD , Nam HH , Hoenigl M . Invasive aspergillosis in critically Ill patients: review of definitions and diagnostic approaches. Mycoses John Wiley and Sons Inc, 2021:1002\u201314.","DOI":"10.1111\/myc.13274"},{"key":"2026073110201957000_thorax-2026-225007v1.12","doi-asserted-by":"publisher","DOI":"10.1086\/318483"},{"key":"2026073110201957000_thorax-2026-225007v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(22)00470-6"},{"key":"2026073110201957000_thorax-2026-225007v1.14","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s40265-022-01785-1","article-title":"Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review","volume":"82","author":"Mart\u00ednez-Garc\u00eda","year":"2022","journal-title":"Drugs"},{"key":"2026073110201957000_thorax-2026-225007v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.1"},{"key":"2026073110201957000_thorax-2026-225007v1.16","doi-asserted-by":"crossref","unstructured":"Potteg\u00e5rd A , Schmidt SAJ , Wallach-Kildemoes H , et al . Data Resource Profile: The Danish National Prescription Registry. Int J Epidemiol 2016;:dyw213. doi:10.1093\/ije\/dyw213","DOI":"10.1093\/ije\/dyw213"},{"key":"2026073110201957000_thorax-2026-225007v1.17","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-014-9930-3"},{"key":"2026073110201957000_thorax-2026-225007v1.18","doi-asserted-by":"crossref","unstructured":"Schmidt M , Schmidt SAJ , Sandegaard JL , et al . The Danish National Patient Registry: a review of content, data quality, and research potential. CLEP 2015;449. doi:10.2147\/CLEP.S91125","DOI":"10.2147\/CLEP.S91125"},{"key":"2026073110201957000_thorax-2026-225007v1.19","doi-asserted-by":"crossref","unstructured":"Liu D , Ahmet A , Ward L , et al . A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. All Asth Clin Immun 2013;9. doi:10.1186\/1710-1492-9-30","DOI":"10.1186\/1710-1492-9-30"},{"key":"2026073110201957000_thorax-2026-225007v1.20","unstructured":"Global Strategy for Asthma Management and Prevention . 2025 gina strategy report - global initiative for asthma - gina. 2025. Available: https:\/\/ginasthma.org\/2025-gina-strategy-report\/ [Accessed 29 Apr 2026]."},{"key":"2026073110201957000_thorax-2026-225007v1.21","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-11-83","article-title":"The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients","volume":"11","author":"Thygesen","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"2026073110201957000_thorax-2026-225007v1.22","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwaa167"},{"key":"2026073110201957000_thorax-2026-225007v1.23","doi-asserted-by":"crossref","first-page":"107962","DOI":"10.1016\/j.rmed.2025.107962","article-title":"Local and systemic adverse effects of inhaled corticosteroids - Does ciclesonide differ from other inhaled corticosteroids?","volume":"238","author":"Ottesen","year":"2025","journal-title":"Respir Med"},{"key":"2026073110201957000_thorax-2026-225007v1.24","unstructured":"Bulpa P , Dive A , Sibille Y . Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease."},{"key":"2026073110201957000_thorax-2026-225007v1.25","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04574-1","article-title":"Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations","volume":"9","author":"Singanayagam","year":"2018","journal-title":"Nat Commun"},{"key":"2026073110201957000_thorax-2026-225007v1.26","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.6.3034-3042.2003"},{"key":"2026073110201957000_thorax-2026-225007v1.27","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109939","article-title":"Epithelial uptake leads to fungal killing in vivo and is aberrant in COPD-derived epithelial cells","volume":"27","author":"Bertuzzi","year":"2024","journal-title":"iScience"},{"key":"2026073110201957000_thorax-2026-225007v1.28","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1099\/13500872-140-9-2475","article-title":"Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis","volume":"140 (Pt 9)","author":"Ng","year":"1994","journal-title":"Microbiology (Reading)"},{"key":"2026073110201957000_thorax-2026-225007v1.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200008243430818"},{"key":"2026073110201957000_thorax-2026-225007v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0953-6205(03)90006-9"},{"key":"2026073110201957000_thorax-2026-225007v1.31","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myu038"},{"key":"2026073110201957000_thorax-2026-225007v1.32","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jcf.2018.01.008","article-title":"Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis","volume":"17","author":"Hong","year":"2018","journal-title":"J Cyst Fibros"},{"key":"2026073110201957000_thorax-2026-225007v1.33","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-018-0574-z"},{"key":"2026073110201957000_thorax-2026-225007v1.34","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03259.x"},{"key":"2026073110201957000_thorax-2026-225007v1.35","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.1.44-69.2005"},{"key":"2026073110201957000_thorax-2026-225007v1.36","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1200\/JCO.1994.12.4.827","article-title":"Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients","volume":"12","author":"O\u2019Donnell","year":"1994","journal-title":"J Clin Oncol"},{"key":"2026073110201957000_thorax-2026-225007v1.37","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2026073110201957000_thorax-2026-225007v1.38","doi-asserted-by":"publisher","DOI":"10.1007\/s12281-023-00456-2"},{"key":"2026073110201957000_thorax-2026-225007v1.39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaci.2017.09.039","article-title":"Corticosteroid treatment is associated with increased filamentous fungal burden in allergic fungal disease","volume":"142","author":"Fraczek","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2026073110201957000_thorax-2026-225007v1.40","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-206291"},{"key":"2026073110201957000_thorax-2026-225007v1.41","doi-asserted-by":"crossref","unstructured":"Patel AR , Patel AR , Singh S , et al . Treating allergic bronchopulmonary aspergillosis: a review. Cureus Cureus, Inc; 2019.","DOI":"10.7759\/cureus.4538"},{"key":"2026073110201957000_thorax-2026-225007v1.42","unstructured":"Dansk Lungemedicinsk Selskab . Kronisk Pulmonal Aspergillose (CPA); 2023."},{"key":"2026073110201957000_thorax-2026-225007v1.43","doi-asserted-by":"crossref","DOI":"10.1186\/s40733-021-00072-2","article-title":"Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma","volume":"7","author":"Jensen","year":"2021","journal-title":"Asthma Res Pract"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2026-225007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:20:35Z","timestamp":1785518435000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2026-225007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":43,"alternative-id":["10.1136\/thorax-2026-225007"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2026-225007","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]}}}